On December 21, 2018, Epidemiology And Treatment Of Allergic Diseases, a scientific and practical conference of the Sverdlovsk region's allergologists and immunologists, was held, where Triazavirin, the domestic antiviral drug, was recommended as a treatment for viral infections that exacerbate bronchial asthma.
Today, the company has a developed technology for obtaining the RosinsulinAspart and RosinsulinGlargin substances as well as their dosage forms.
On November 15, 2018, within the framework of a regular meeting of the Sverdlovsk Association of Endocrinologists, the results of clinical trials of Rosinsulin M Mix 30/70, 2-phase genetically engineered human insulin, were presented in Rymar Oksana's report “Basic clinical and laboratory parameters in patients with type 2 diabetes mellitus amid the therapy of combined domestic insulins and metformins in the real-world clinical practice."
On July 19, the Medsintez plant arranged the first open excursion for schoolchildren as part of an educational Science program. It involved talented students from 30 municipalities of the Sverdlovsk Region. They have already learned most of the lecture material from such areas as the medicine of the future, chemistry and pharmacy. This July educational program was organized by the Golden Section Fund, which supports talented children and youth. The excursion to the plant promoted knowledge consolidation.
+7 (34370) 2-50-61
+7 (34370) 2-54-95
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130